INVESTINGBiogen Shares Surge On FDA Application For Alzheimer's TreatmentBy Martin BaccardaxJul 8, 2020 11:25 AM EDT
PRESS RELEASESMiMedx Announces Concurrent $150 Million Private Equity And Debt FinancingsBy GlobeNewswireJul 2, 2020 9:00 AM EDT
INVESTINGBiogen Stock Off After Barclays Downgrade on Patent RulingBy Rob LenihanJun 22, 2020 12:04 PM EDT
INVESTINGBiogen Loses Court Decision to Mylan Over Multiple Sclerosis DrugBy Dan WeilJun 18, 2020 11:08 AM EDT
JIM CRAMERLive With It: Cramer's 'Mad Money' Recap (Wednesday 6/17/20)By Scott RuttJun 17, 2020 9:44 PM EDT
INVESTINGBiogen Cut at Bernstein, Reiterated Neutral at J.P. MorganBy Tony OwusuJun 9, 2020 11:35 AM EDT
INVESTINGBuffett Exits Phillips 66 and Travelers, Trims Goldman SachsBy Tom BemisMay 15, 2020 7:37 PM EDT
INVESTINGBiogen Reports Better-Than-Expected Earnings - Stock LowerBy Dan WeilApr 22, 2020 8:32 AM EDT
MARKETSNetflix, Delta, Snap, Chipotle and Oil Prices - 5 Things You Must Know WednesdayBy Joseph WoelfelApr 22, 2020 7:09 AM EDT
PRESS RELEASESThinking About Trading Options Or Stock In Biogen, Clorox, Centene, Netflix, Or Walmart?By PR NewswireMar 16, 2020 9:31 AM EDT
LATEST NEWSNation's Top Doc: We're Already Seeing Community SpreadBy Adam SmithMar 8, 2020 5:47 PM EDT
JIM CRAMERFight the Fear: Cramer's 'Mad Money' Recap (Thursday 3/5/20)By Scott RuttMar 5, 2020 9:06 PM EST
PRESS RELEASESBiogen And Sangamo Announce Global Collaboration To Develop Gene Regulation Therapies For Alzheimer's, Parkinson's, Neuromuscular, And Other Neurological DiseasesBy Business WireFeb 27, 2020 4:06 PM EST
INVESTINGWarren Buffett’s Berkshire Hathaway Set to Report Earnings SaturdayBy Tom BemisFeb 21, 2020 3:02 PM EST
INVESTINGWarren Buffett’s Berkshire Hathaway Takes Stakes in Kroger, Biogen; Cuts Banks and AppleBy Tom BemisFeb 14, 2020 7:58 PM EST
INVESTINGBiogen Beats Back Mylan Patent Challenge Over MS Drug TecfideraBy Rob LenihanFeb 5, 2020 3:16 PM EST
MARKETSS&P 500 and Nasdaq Close at Record Highs as Rally Extends to a Third DayBy Joseph WoelfelFeb 5, 2020 2:40 PM EST
INVESTINGBiogen Beats Q4 Estimates on Strong Sales of Treatments for MS, Spinal AtrophyBy Tony OwusuJan 30, 2020 9:20 AM EST
MARKETSMicrosoft, Tesla, Coronavirus, Facebook and Amazon - 5 Things You Must Know ThursdayBy Joseph WoelfelJan 30, 2020 7:09 AM EST
INVESTINGAcceleron Soars in After-Hours Trading on Positive Trial Results for Hypertension TreatmentBy Tom BemisJan 27, 2020 5:37 PM EST
PRESS RELEASESBehind The Seizure® Program Further Expands Access To Genetic Testing For Children To Speed The Diagnosis Of Genetic EpilepsyBy PR NewswireJan 8, 2020 2:30 AM EST
INVESTINGBristol-Myers, Gilead, Biogen, Other Drugmakers Increased U.S. List Prices on Jan. 1: ReportBy Rob LenihanJan 2, 2020 1:41 PM EST
